Pfizer Global Security Regional Director Harry Waskiewicz On Busting Counterfeit Drugs: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Pfizer case studies show counterfeiting now goes far beyond a Viagra problem.
You may also be interested in...
China Broadens Scope Of Counterfeit Drugs For Criminal Prosecution, But Definition Still Murky
SHANGHAI - China recently broadened its criminal definition of counterfeit drugs to include all counterfeits, not just those that cause damage to human health. The revised Criminal Law opens more manufacturers of counterfeit drugs to criminal prosecution and makes prison terms mandatory for guilty parties
China’s Simcere Receives Buyout Offer From Its Chairman, But Could Delisting Be A Negative Overseas?
Simcere would join Chinese firms 3SBio and ShangPharma in pulling out of the U.S. stock market.
China’s New Good Supply Practices Regs Require Electronic Barcodes; Raise Bar To Entry
The Ministry of Health’s GSP regulation tries to plug a hole in supply chain security through tighter IT controls, such as requiring electronic barcodes.